AIM
Price:
$0.4059
Market Cap:
$1.38M
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ov...[Read more]
Industry
Biotechnology
IPO Date
1995-11-02
Stock Exchange
AMEX
Ticker
AIM
According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 139.50K. This represents a change of -98.33% compared to the average of 8.38M of the last 4 quarters.
The mean historical Enterprise Value of AIM ImmunoTech Inc. over the last ten years is 39.13M. The current 139.50K Enterprise Value has changed -64.35% with respect to the historical average. Over the past ten years (40 quarters), AIM's Enterprise Value was at its highest in in the June 2021 quarter at 225.76M. The Enterprise Value was at its lowest in in the March 2026 quarter at 1.30M.
Average
39.13M
Median
28.38M
Minimum
5.79M
Maximum
111.62M
Discovering the peaks and valleys of AIM ImmunoTech Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.01%
Maximum Annual Enterprise Value = 111.62M
Minimum Annual Increase = -84.66%
Minimum Annual Enterprise Value = 5.79M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 5.79M | -80.88% |
| 2024 | 30.31M | -40.27% |
| 2023 | 50.73M | 308.34% |
| 2022 | 12.42M | -84.66% |
| 2021 | 81.02M | -27.42% |
| 2020 | 111.62M | 1.01% |
| 2019 | 10.01M | -61.87% |
| 2018 | 26.26M | -0.75% |
| 2017 | 26.45M | -27.79% |
| 2016 | 36.63M | -21.86% |
The current Enterprise Value of AIM ImmunoTech Inc. (AIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
28.94M
5-year avg
36.06M
10-year avg
39.13M
AIM ImmunoTech Inc.’s Enterprise Value is less than KALA BIO, Inc. (55.91M), greater than Oragenics, Inc. (-3242702.00), greater than Pasithea Therapeutics Corp. (-46001320.00), greater than VYNE Therapeutics Inc. (-13823812.00), less than Quoin Pharmaceuticals, Ltd. (5.31M), less than Ensysce Biosciences, Inc. (1.83M), less than XTL Biopharmaceuticals Ltd. (5.59M), less than Alaunos Therapeutics, Inc. (5.17M), less than Can-Fite BioPharma Ltd. (7.43B), greater than Soligenix, Inc. (-1266892.00),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 55.91M | $57.68M | |
| -3242702.00 | $2.81M | |
| -46001320.00 | $4.40M | |
| -13823812.00 | $10.81M | |
| 5.31M | $8.43M | |
| 1.83M | $2.33M | |
| 5.59M | $5.04M | |
| 5.17M | $5.52M | |
| 7.43B | $1.53M | |
| -1266892.00 | $4.43M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is AIM ImmunoTech Inc.'s Enterprise Value?
What is the highest Enterprise Value for AIM ImmunoTech Inc. (AIM)?
What is the 3-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?
What is the 5-year average Enterprise Value for AIM ImmunoTech Inc. (AIM)?
How does the current Enterprise Value for AIM ImmunoTech Inc. (AIM) compare to its historical average?